Literature DB >> 15866711

Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli.

Xiaopu Yin1, Dongzhi Wei, Lina Yi, Xinyi Tao, Yushu Ma.   

Abstract

Exendin-4 is a 39 amino acid peptide isolated from salivary secretions of Gila monster (Heloderma suspectum). It shows 53% sequence similarity to glucagon-like peptide-1 (GLP-1), which is evaluated for the regulation of plasma glucose in type 2 diabetes. Exendin-4 is a potent and long-acting agonist of GLP-1 receptor. In the present study, the exendin-4 gene obtained by PCR with an enterokinase site at N-terminus and a termination codon at C-terminus was expressed in Escherichia coli strain BL21 (DE3) harboring pET32a(+). The fusion protein was purified by chromatography on Ni-NTA-agarose column. Recombinant exendin-4 was obtained by enterokinase cleavage of the fusion protein and subsequent purification. The yield of recombinant exendin-4 was 3.15mg/10g bacteria. The obtained recombinant exendin-4 shows glucose-lowering action in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866711     DOI: 10.1016/j.pep.2004.10.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  cDNA clone, fusion expression and purification of the novel gene related to ascorbate peroxidase from Chinese wild Vitis pseudoreticulata in E. coli.

Authors:  Ling Lin; Xiping Wang; Yuejin Wang
Journal:  Mol Biol Rep       Date:  2006-09       Impact factor: 2.316

2.  Characterization and site-directed mutation of a novel aldo-keto reductase from Lodderomyces elongisporus NRRL YB-4239 with high production rate of ethyl (R)-4-chloro-3-hydroxybutanoate.

Authors:  Qiuyan Wang; Tingting Ye; Zhuanzhuan Ma; Rong Chen; Tian Xie; Xiaopu Yin
Journal:  J Ind Microbiol Biotechnol       Date:  2014-09-05       Impact factor: 3.346

3.  Pharmacological validation of candidate causal sleep genes identified in an N2 cross.

Authors:  Joseph I Brunner; Anthony L Gotter; Joshua Millstein; Susan Garson; Jacquelyn Binns; Steven V Fox; Alan T Savitz; He S Yang; Karrie Fitzpatrick; Lili Zhou; Joseph R Owens; Andrea L Webber; Martha H Vitaterna; Andrew Kasarskis; Victor N Uebele; Fred Turek; John J Renger; Christopher J Winrow
Journal:  J Neurogenet       Date:  2011-12       Impact factor: 1.250

Review 4.  Targeting Persistent Neuroinflammation after Hypoxic-Ischemic Encephalopathy-Is Exendin-4 the Answer?

Authors:  Kelly Q Zhou; Simerdeep K Dhillon; Laura Bennet; Alistair J Gunn; Joanne O Davidson
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

5.  Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris.

Authors:  Jin Zhou; Ju Chu; Yong-Hong Wang; Hui Wang; Ying-Ping Zhuang; Si-Liang Zhang
Journal:  Biotechnol Lett       Date:  2007-12-01       Impact factor: 2.461

6.  Design and implementation of a high yield production system for recombinant expression of peptides.

Authors:  Vida Rodríguez; Juan A Asenjo; Barbara A Andrews
Journal:  Microb Cell Fact       Date:  2014-05-07       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.